Non-cardiac surgery and antiplatelet therapy following coronary artery stenting

Area of Science:

• Cardiology
• Vascular Medicine
• Interventional Cardiology

Background:

• Coronary artery stenting is a common treatment for coronary artery disease.
• Antiplatelet therapy is essential post-stenting to prevent stent thrombosis.
• A significant percentage of patients require non-cardiac surgery within a year of stenting.

Purpose of the Study:

• To review the evidence guiding antiplatelet therapy management in patients undergoing non-cardiac surgery after coronary stenting.
• To highlight the complex balance between operative hemorrhage and stent thrombosis risks.
• To provide a framework for clinical decision-making in this challenging scenario.

Main Methods:

• Literature review of existing evidence and guidelines.
• Analysis of risk factors for stent thrombosis and bleeding.
• Synthesis of data to inform management strategies.

Main Results:

• Management requires careful consideration of individual patient risk profiles.
• Discontinuation of antiplatelet therapy increases stent thrombosis risk.
• Continuing antiplatelet therapy increases operative bleeding risk.

Conclusions:

• Individualized patient assessment is key for managing antiplatelet therapy.
• Shared decision-making between cardiology and surgical teams is vital.
• Further research is needed to optimize antiplatelet strategies in this population.